LifeVantage Corporation

LFVN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $5.8M $1.6M $6.1M $7.1M $11.4M $7.6M $12.5M $-50.8M
Depreciation & Amortization $1.3M $1.6M $1.9M $2.3M $2.1M $1.7M $521.0K $215.0K
Depreciation $1.2M $1.5M $1.8M $2.3M $2.0M $1.5M $400.0K $100.0K
Amortization $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K
Stock-Based Compensation $3.2M $2.6M $2.6M $1.8M $3.0M $2.2M $1.3M $767.0K
Net Cash from Operating Activities $13.3M $6.6M $6.0M $13.2M $12.1M $10.7M $19.4M $4.7M
Investing Activities
Capital Expenditures $4.6M $1.1M $562.0K $1.2M $1.9M $5.1M $2.2M $122.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-4.6M $-1.1M $-562.0K $-1.2M $-2.2M $-5.1M $-1.9M $-89.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $1.5M $0 $0 $9.9M $46.2M $7.1M $976.0K $0
Net Cash from Financing Activities $-3.5M $-2.0M $-11.7M $-18.5M $-15.8M $-4.0M $746.0K $169.0K
Net Change in Cash $5.2M $3.6M $-6.0M $-6.5M $-5.9M $1.7M $18.3M $4.7M
Free Cash Flow $8.6M $5.5M $5.5M $12.1M $10.2M $5.6M $17.2M $4.6M
← Newer Page 2 of 2 Older →